Skip to main content
logo
Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.280
-0.090 (-6.57%)
At close: Jun 15, 2026, 4:00 PM EDT
1.300
+0.020 (1.56%)
After-hours: Jun 15, 2026, 5:06 PM EDT

Pulmonx Revenue

Pulmonx had revenue of $20.59M in the quarter ending March 31, 2026, a decrease of -8.66%. This brings the company's revenue in the last twelve months to $88.55M, up 1.23% year-over-year. In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth.

Revenue (ttm)
$88.55M
Revenue Growth
+1.23%
P/S Ratio
0.61
Revenue / Employee
$299,139
Employees
296
Market Cap
54.06M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202590.50M6.71M8.01%
Dec 31, 202483.79M15.11M22.01%
Dec 31, 202368.68M15.01M27.98%
Dec 31, 202253.66M5.25M10.84%
Dec 31, 202148.42M15.68M47.91%
Dec 31, 202032.73M138.00K0.42%
Dec 31, 201932.60M12.59M62.94%
Dec 31, 201820.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Accuray428.57M
Xtant Medical Holdings121.91M
Nortech Systems121.79M
LENSAR57.70M
Myomo41.21M
QT Imaging Holdings22.66M
Sensus Healthcare22.53M
Spectral AI16.93M
Revenue Rankings

LUNG News

More News